A polycystás ovarium syndroma etiológiája, diagnosztikája és kezelése

Translated title of the contribution: Etiology, diagnosis and management of polycystic ovary syndrome

András Szilágyi, I. Szabó

Research output: Contribution to journalArticle

Abstract

Diagnostic criteria for polycystic ovary syndrome (PCOS) have not been standardized until the recently postulated recommendations, while the classical European and American criteria are different. The controversies seem to have been resolved by the Rotterdam Consensus Conference held in 2003 where the gap between the European and American criteria was surmounted and standardized diagnostic recommendations were presented. Based on the new criteria the diagnosis of PCOS could be set if two of the three diagnostic criteria are fulfilled (oligo- or anovulation, clinical and/or biochemical signs of hyperandrogenism, polycystic ovaries) and furthermore, other diseases like 21 hydroxylase deficiency can be ruled out. Concerning the management of PCOS the recommendations are less evident, which may be attributable to the aetiological uncertainty. Treatment depends on the demands of the patient (infertility, hyperandrogenism), however the long-term metabolic risk (diabetes, metabolic syndrome) and the oncological risk (endometrial cancer) should also be considered. The use of insulin sensitizing agents has gained increasing significance for all the indications, as these may represent causal treatment, however their exact indications and the length of the treatment have not been clarified as yet.

Original languageHungarian
Pages (from-to)235-244
Number of pages10
JournalMagyar Noorvosok Lapja
Volume68
Issue number4
Publication statusPublished - 2005

Fingerprint

Polycystic Ovary Syndrome
Hyperandrogenism
Anovulation
Endometrial Neoplasms
Infertility
Uncertainty
Ovary
Therapeutics
Insulin

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

A polycystás ovarium syndroma etiológiája, diagnosztikája és kezelése. / Szilágyi, András; Szabó, I.

In: Magyar Noorvosok Lapja, Vol. 68, No. 4, 2005, p. 235-244.

Research output: Contribution to journalArticle

@article{45cefa2514f94c1f96c155db230d7f96,
title = "A polycyst{\'a}s ovarium syndroma etiol{\'o}gi{\'a}ja, diagnosztik{\'a}ja {\'e}s kezel{\'e}se",
abstract = "Diagnostic criteria for polycystic ovary syndrome (PCOS) have not been standardized until the recently postulated recommendations, while the classical European and American criteria are different. The controversies seem to have been resolved by the Rotterdam Consensus Conference held in 2003 where the gap between the European and American criteria was surmounted and standardized diagnostic recommendations were presented. Based on the new criteria the diagnosis of PCOS could be set if two of the three diagnostic criteria are fulfilled (oligo- or anovulation, clinical and/or biochemical signs of hyperandrogenism, polycystic ovaries) and furthermore, other diseases like 21 hydroxylase deficiency can be ruled out. Concerning the management of PCOS the recommendations are less evident, which may be attributable to the aetiological uncertainty. Treatment depends on the demands of the patient (infertility, hyperandrogenism), however the long-term metabolic risk (diabetes, metabolic syndrome) and the oncological risk (endometrial cancer) should also be considered. The use of insulin sensitizing agents has gained increasing significance for all the indications, as these may represent causal treatment, however their exact indications and the length of the treatment have not been clarified as yet.",
keywords = "Diagnosis, Management, Pathophysiology, Polycystic ovary syndrome",
author = "Andr{\'a}s Szil{\'a}gyi and I. Szab{\'o}",
year = "2005",
language = "Hungarian",
volume = "68",
pages = "235--244",
journal = "Magyar Noorvosok Lapja",
issn = "0025-021X",
publisher = "Magyar Noovos Tarsasag",
number = "4",

}

TY - JOUR

T1 - A polycystás ovarium syndroma etiológiája, diagnosztikája és kezelése

AU - Szilágyi, András

AU - Szabó, I.

PY - 2005

Y1 - 2005

N2 - Diagnostic criteria for polycystic ovary syndrome (PCOS) have not been standardized until the recently postulated recommendations, while the classical European and American criteria are different. The controversies seem to have been resolved by the Rotterdam Consensus Conference held in 2003 where the gap between the European and American criteria was surmounted and standardized diagnostic recommendations were presented. Based on the new criteria the diagnosis of PCOS could be set if two of the three diagnostic criteria are fulfilled (oligo- or anovulation, clinical and/or biochemical signs of hyperandrogenism, polycystic ovaries) and furthermore, other diseases like 21 hydroxylase deficiency can be ruled out. Concerning the management of PCOS the recommendations are less evident, which may be attributable to the aetiological uncertainty. Treatment depends on the demands of the patient (infertility, hyperandrogenism), however the long-term metabolic risk (diabetes, metabolic syndrome) and the oncological risk (endometrial cancer) should also be considered. The use of insulin sensitizing agents has gained increasing significance for all the indications, as these may represent causal treatment, however their exact indications and the length of the treatment have not been clarified as yet.

AB - Diagnostic criteria for polycystic ovary syndrome (PCOS) have not been standardized until the recently postulated recommendations, while the classical European and American criteria are different. The controversies seem to have been resolved by the Rotterdam Consensus Conference held in 2003 where the gap between the European and American criteria was surmounted and standardized diagnostic recommendations were presented. Based on the new criteria the diagnosis of PCOS could be set if two of the three diagnostic criteria are fulfilled (oligo- or anovulation, clinical and/or biochemical signs of hyperandrogenism, polycystic ovaries) and furthermore, other diseases like 21 hydroxylase deficiency can be ruled out. Concerning the management of PCOS the recommendations are less evident, which may be attributable to the aetiological uncertainty. Treatment depends on the demands of the patient (infertility, hyperandrogenism), however the long-term metabolic risk (diabetes, metabolic syndrome) and the oncological risk (endometrial cancer) should also be considered. The use of insulin sensitizing agents has gained increasing significance for all the indications, as these may represent causal treatment, however their exact indications and the length of the treatment have not been clarified as yet.

KW - Diagnosis

KW - Management

KW - Pathophysiology

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=22344444697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22344444697&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:22344444697

VL - 68

SP - 235

EP - 244

JO - Magyar Noorvosok Lapja

JF - Magyar Noorvosok Lapja

SN - 0025-021X

IS - 4

ER -